These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9229835)

  • 1. [The effect of the new angiotensin-converting enzyme inhibitor moexipril on the circadian rhythms of arterial pressure in hypertension patients].
    Ol'binskaia LI; Andrushchishina TB
    Ter Arkh; 1997; 69(3):58-61. PubMed ID: 9229835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moexipril in the treatment of mild to moderate essential hypertension: comparison with sustained-release verapamil.
    Abernethy DR; Fox AA; Stimpel M
    J Clin Pharmacol; 1995 Aug; 35(8):794-9. PubMed ID: 8522636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
    Persson B; Stimpel M
    Eur J Clin Pharmacol; 1996; 50(4):259-64. PubMed ID: 8803515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M; Koch B; Jansen T; Fox A; Loh I
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
    White WB; Koch B; Stimpel M
    Am J Ther; 1997 Apr; 4(4):123-9. PubMed ID: 10423601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause.
    Agabiti-Rosei E; Ambrosioni E; Pirelli A; Stimpel M; Zanchetti A
    Eur J Clin Pharmacol; 1999 May; 55(3):185-9. PubMed ID: 10379633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of moexipril in the treatment of hypertension.
    White WB; Fox AA; Stimpel M
    J Hum Hypertens; 1994 Dec; 8(12):917-21. PubMed ID: 7884791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.
    White WB; Whelton A; Fox AA; Stimpel M; Kaihlanen PM
    J Clin Pharmacol; 1995 Mar; 35(3):233-8. PubMed ID: 7608310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB; Stimpel M
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].
    Ostroumova OD; Paukov SV; Frolova LI
    Kardiologiia; 2006; 46(11):92-8. PubMed ID: 17159885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moexipril. A review of its use in the management of essential hypertension.
    Brogden RN; Wiseman LR
    Drugs; 1998 Jun; 55(6):845-60. PubMed ID: 9617599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M; Koch B; Oparil S
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of moexipril, a new ACE inhibitor, as add-on therapy to nifedipine in patients with essential hypertension.
    Persson B; Widgren BR; Fox A; Stimpel M
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):73-8. PubMed ID: 7564369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moexipril: another ACE inhibitor for hypertension.
    Med Lett Drugs Ther; 1995 Sep; 37(956):75-6. PubMed ID: 7637658
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian heart rate variability in patients with primary arterial hypertension.
    Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
    Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats.
    Stimpel M; Jee WS; Ma Y; Yamamoto N; Chen Y
    J Hypertens; 1995 Dec; 13(12 Pt 2):1852-6. PubMed ID: 8903666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.